Medspera Pharmaceuticals Private Limited

Rybelsus 14mg (semaglutide) tablets are a once-daily, oral GLP-1 receptor agonist prescribed to improve glycemic control in adults with type 2 diabetes, often as a, added to diet and exercise. It works by stimulating insulin release, reducing sugar production, and slowing digestion. 14mg is usually a maintenance dose following a 7mg dose. 

Rybelsus (semaglutide) 3mg tablets are a prescription medication used to improve blood sugar (glucose) control in adults with Type 2 diabetes, typically used as an initial 30-day starter dose to help the body adjust. It acts as a GLP-1 receptor agonist, reducing blood sugar by increasing insulin release and reducing glucagon. 

Rybelsus 7mg (semaglutide) tablets are a daily prescription medication used to improve blood sugar (glucose) control in adults with Type 2 diabetes, typically used after a 30-day starter dose of 3mg. It acts as a GLP-1 receptor agonist to increase insulin release, reduce glucagon, and slow digestion.